CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mobley, J. A.
Right arrow Articles by Ho, S.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mobley, J. A.
Right arrow Articles by Ho, S.-M.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 775-783, August 2003
© 2003 American Association for Cancer Research

Branched Fatty Acids in Dairy and Beef Products Markedly Enhance {alpha}-Methylacyl-CoA Racemase Expression in Prostate Cancer Cells in Vitro1

James A. Mobley, Irwin Leav, Patrick Zielie, Chad Wotkowitz, James Evans, Ying-Wai Lam, Byung Suk L’Esperance, Zhong Jiang and Shuk-Mei Ho2

Department of Surgery, Division of Urology and Departments of Pathology, Biochemistry and Pharmacology, and Cell Biology and Physiology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, and Department of Pathology, School of Veterinary Medicine, Tufts University, Grafton, Massachusetts

An enzyme previously identified as {alpha}-methylacyl-CoA racemase (AMACR) is overexpressed in high-grade prostatic intraepithelial neoplasia and in a majority (60–100%) of prostate cancers (CaPs) as compared with normal and benign hyperplastic lesions of the prostate, where it is minimally expressed. This enzyme is required for the ß-oxidation of branched-chain fatty acids, which include phytanic acid and its {alpha}-oxidation product, pristanic acid. Interestingly, there is an established correlation between CaP risk and the consumption of dairy and beef products, which also contain marked quantities of these two phytols. In this context, it has also been reported that sex steroids influence lipogenesis through the induction of fatty acid synthase in CaP-derived cell lines and CaP tissues. These findings indicate a potential role for AMACR and the possible influence of sex steroids in both the early development and subsequent progression of CaP. Despite the recent interest in AMACR as a histological marker for CaP, little is known about the regulation of this enzyme and its role in CaP development. To identify potential AMACR-regulating factors, we treated LNCaP cells (an androgen-responsive CaP-derived cell line) and NPrEC cells (a normal prostate basal epithelial cell line) with increasing concentrations of pristanic acid, phytanic acid, 5{alpha}-dihydrotestosterone, and 17ß-estradiol. Neither the biologically potent androgen 5{alpha}-dihydrotestosterone nor 17ß-estradiol had any apparent effect on AMACR expression at the protein or transcriptional levels in either cell line. Conversely, pristanic acid and, to a much lesser extent, phytanic acid markedly increased AMACR protein levels selectively in the LNCaP cell line, but not the NPrEC cell line. However, no change was measured at the transcriptional level in either cell line. AMACR is therefore significantly increased at the protein level in CaP cells, through what appears to be the stabilizing effect of the same fatty acids that are present at appreciable concentrations in beef and dairy products, which have been associated with CaP risk. Our findings therefore provide a link between the consumption of dietary fatty acids and the enhanced expression of AMACR, an enzyme that may play an important role in genesis and progression of CaP.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. E. Daugherty, E. A. Platz, Y. Y. Shugart, M. D. Fallin, W. B. Isaacs, N. Chatterjee, R. Welch, W.-Y. Huang, and R. B. Hayes
Variants in the {alpha}-Methylacyl-CoA Racemase Gene and the Association with Advanced Distal Colorectal Adenoma
Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1536 - 1542.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. K. Witkiewicz, S. Varambally, R. Shen, R. Mehra, M. S. Sabel, D. Ghosh, A. M. Chinnaiyan, M. A. Rubin, and C. G. Kleer
{alpha}-Methylacyl-CoA Racemase Protein Expression Is Associated with the Degree of Differentiation in Breast Cancer Using Quantitative Image Analysis
Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1418 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S. Zha and W. B. Isaacs
A Nonclassic CCAAT Enhancer Element Binding Protein Binding Site Contributes to {alpha}-Methylacyl-CoA Racemase Expression in Prostate Cancer
Mol. Cancer Res., February 1, 2005; 3(2): 110 - 118.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.